Table:
begin	end	state
1	9	cytoplasmic
10	29	transmembrane
30	40	non-cytoplasmic
41	60	transmembrane
61	92	cytoplasmic
93	117	transmembrane
118	124	non-cytoplasmic
125	144	transmembrane
145	150	cytoplasmic
151	176	transmembrane
177	201	non-cytoplasmic
202	222	transmembrane
223	233	cytoplasmic
234	256	transmembrane
257	281	non-cytoplasmic
282	310	transmembrane
311	330	cytoplasmic
331	352	transmembrane
353	357	non-cytoplasmic
358	382	transmembrane
383	394	cytoplasmic
395	413	transmembrane
414	418	non-cytoplasmic
419	437	transmembrane
438	448	cytoplasmic
449	469	transmembrane
470	475	non-cytoplasmic

Input:
>Pf6N2E2_2906
MPQPIEKLPLGALIALVVGSMIGGGIFSLPQNMAARADVGAVLIGWAITAIGMLTLAFVF
QTLANRKPQLNSGVYAYAKAGFGDYMGFSSAWGYWISAWLGNVGYFVLLFSTLGYFFPVF
GQGNTPVAIGCASLLLWAVHFLVLRGIQEAAFINLVTTVAKVVPLLMFVVMAAVAFKAEV
FTRDIWGAMNPDLGSVMDQVRNMMLVTVFVFIGIEGASVYSARAERRADVGRATVIGFLG
VLALLVLVNVLSLGVMSQRELAQLQNPSLAGVLEHIVGPWGALLISLGLAVSLLGALLSW
ALLCAEILYATARDKTMPAFLTKENANRAPVNALWLTNGMIQLFLLITLFSAGTYTSLIY
LASSMILVPYLWSAAYAVLLCARGETYEQGSARRMKDLCIGGVALCYAVWLLYAGGVKYL
LLSALLYAPGVILFAQAKREQGQPLFTHVEKGVFACVMAGAGGAAYGLYSGFLEL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server